M
Marie I. Samanovic
Researcher at New York University
Publications - 53
Citations - 2172
Marie I. Samanovic is an academic researcher from New York University. The author has contributed to research in topics: Vaccination & Antibody. The author has an hindex of 18, co-authored 41 publications receiving 1181 citations.
Papers
More filters
Journal ArticleDOI
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.
Bryan Edward Jones,Patricia Brown-Augsburger,Kizzmekia S. Corbett,Kathryn Westendorf,Julian Davies,Thomas P. Cujec,Christopher M. Wiethoff,Jamie L. Blackbourne,Beverly A. Heinz,Denisa Foster,Richard E. Higgs,Deepa Balasubramaniam,Lingshu Wang,Yi Zhang,Eun Sung Yang,Roza Bidshahri,Lucas Kraft,Yuri Hwang,Stefanie Žentelis,Kevin R. Jepson,Rodrigo Goya,Maia A. Smith,David Collins,Samuel J. Hinshaw,Sean A. Tycho,Davide Pellacani,Ping Xiang,Krithika Muthuraman,Solmaz Sobhanifar,Marissa H. Piper,Franz J. Triana,Jorg Hendle,A. Pustilnik,Andrew C. Adams,Shawn J. Berens,Ralph S. Baric,David R. Martinez,Robert W. Cross,Thomas W. Geisbert,Viktoriya Borisevich,Olubukola M. Abiona,Hayley M. Belli,Maren de Vries,Adil Mohamed,Meike Dittmann,Marie I. Samanovic,Mark J. Mulligan,Jory A. Goldsmith,Ching-Lin Hsieh,Nicole V. Johnson,Daniel Wrapp,Jason S. McLellan,Bryan C. Barnhart,Barney S. Graham,John R. Mascola,Carl L. Hansen,Ester Falconer +56 more
TL;DR: A microfluidic screening of antigen-specific B cells led to the identification of LY-CoV555 (also known as bamlanivimab), a potent anti-spike neutralizing antibody from a hospitalized, convalescent patient with coronavirus disease 2019 (COVID-19) as discussed by the authors.
Journal ArticleDOI
Copper in Microbial Pathogenesis: Meddling with the Metal
TL;DR: Evidence that animals use copper as an antimicrobial weapon and that microbes have developed mechanisms to counteract the toxic effects of copper are reviewed.
Journal ArticleDOI
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
Rebecca H. Haberman,Ramin S. Herati,David Simon,Marie I. Samanovic,Rebecca B Blank,Michael Tuen,Sergei B. Koralov,Raja Atreya,Koray Tascilar,Joseph R. Allen,Rochelle Castillo,Amber Cornelius,Paula Rackoff,Gary Solomon,Samrachana Adhikari,Natalie Azar,Pamela Rosenthal,Peter M. Izmirly,Jonathan Samuels,Brian D. Golden,Soumya M. Reddy,Markus F. Neurath,Steven B. Abramson,Georg Schett,Mark J. Mulligan,Jose U. Scher +25 more
TL;DR: In this article, the authors investigated the humoral and cellular immune response to COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment.
Posted ContentDOI
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
Bryan Edward Jones,Patricia Brown-Augsburger,Kizzmekia S. Corbett,Kathryn Westendorf,Julian Davies,Thomas P. Cujec,Christopher M. Wiethoff,Jamie L. Blackbourne,Beverly A. Heinz,Denisa Foster,Richard E. Higgs,Deepa Balasubramaniam,Lingshu Wang,Roza Bidshahri,Lucas Kraft,Yuri Hwang,Stefanie Zentelis,Kevin R. Jepson,Rodrigo Goya,Maia A. Smith,David Collins,Samuel J. Hinshaw,Sean A. Tycho,Davide Pellacani,Ping Xiang,Krithika Muthuraman,Solmaz Sobhanifar,Marissa H. Piper,Franz J. Triana,Jorg Hendle,A. Pustilnik,Andrew C. Adams,Shawn J. Berens,Ralph S. Baric,David R. Martinez,Robert W. Cross,Thomas W. Geisbert,Viktoriya Borisevich,Olubukola M. Abiona,Hayley M. Belli,Maren de Vries,Adil Mohamed,Meike Dittmann,Marie I. Samanovic,Mark J. Mulligan,Jory A. Goldsmith,Ching-Lin Hsieh,Nicole V. Johnson,Daniel Wrapp,Jason S. McLellan,Bryan C. Barnhart,Barney S. Graham,John R. Mascola,Carl L. Hansen,Ester Falconer +54 more
TL;DR: High-throughput microfluidic screening of antigen-specific B-cells led to the identification of LY-CoV555, a potent anti-spike neutralizing antibody derived from a convalescent COVID-19 patient that protects the upper and lower airways of non-human primates against SARS- CoV-2 infection.
Journal ArticleDOI
Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model
TL;DR: It is concluded that all three human apolipoproteins act cooperatively to achieve maximal killing capacity and that truncatedApolipoprotein L-I does not function in transgenic animals.